Keywords: Hospira, Taxotere, Docetaxel, FDA, Generic, Sanofi-Aventis, Cancer

Hospira gains US clearance for first generic of Sanofi-Aventis’ Taxotere

Article | 10 March 2011

USA-based Hospira (NYSE: HSP), a specialist in generic injectable pharmaceuticals, yesterday revealed that the US Food and Drug Administration has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Hospira

Sanofi-Aventis

Go to company listing

Related Drugs

docetaxel

Taxotere

Go to drug listing